Search Within

Monica Morrow

Formats
  1. Journal Article (408)
  2. Meeting Abstract (251)
  3. Miscellaneous (34)
  4. Book Section (24)
  5. Editorial (24)
  6. Review (18)
  7. Correspondence (10)
  8. Book Whole (4)
  9. Conference Paper (4)
  10. Guidelines (3)
Groups
  1. Surgery (780)
  2. Epidemiology and Biostatistics (274)
  3. Survivorship Research (269)
  4. Department of Pathology and Laboratory Medicine (145)
  5. Department of Medicine (135)
  6. Josie Robertson Surgery Center (135)

More Groups

People
  1. Srinivasa Sevilimedu Veeravalli (134)
  2. Michelle Stempel (110)
  3. Andrea Barrio (97)
  4. Audree Tadros (86)
  5. Sujata Patil (83)
  6. Kimberly Van Zee (75)

More People

Years
  1. 2025 (17)
  2. 2024 (43)
  3. 2023 (47)
  4. 2022 (54)
  5. 2021 (57)
  6. 2020 (54)

More Years

Publications
  1. Annals of Surgical Oncology (308)
  2. Journal of Clinical Oncology (86)
  3. Cancer Research (36)
  4. International Journal of Radiation Oncology, Biology, Physics (31)
  5. Breast Cancer Research and Treatment (23)
  6. Cancer (22)

More Publications

Publishers
  1. Springer (342)
  2. American Society of Clinical Oncology (88)
  3. Elsevier Inc. (70)
  4. American Association for Cancer Research (46)
  5. American Medical Association (46)
  6. Lippincott Williams & Wilkins (33)

More Publishers

Results (780)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Can clinicopathologic features identify patients with HR+/HER2- tumors and palpable adenopathy who have low volume axillary disease?
    Meeting Abstract

    Crown, A.; Sevilimedu, V.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Is heroic mastectomy effective in maintaining local control for classically inoperable breast cancers?
    Meeting Abstract

    Mamtani, A.; Sevilimedu, V.; Vincent, A.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Is locoregional recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
    Meeting Abstract

    Mamtani, A.; Sevilimedu, V.; Le, T.; Morrow, M.; Barrio, A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Do local anesthetics reduce opioid requirement and pain scores after lumpectomy and sentinel node biopsy with multimodal analgesia?
    Meeting Abstract

    Pawloski, K. R.; Sevilimedu, V.; Twersky, R.; Tadros, A.; Kirstein, L.; Cody, H.; Morrow, M.; Moo, T.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Reconstruction in women with T4 breast cancer after neoadjuvant chemotherapy: When is it safe?
    Meeting Abstract

    Pawloski, K. R.; Gemignani, M. L.; Sevilimedu, V.; Le, T.; Dayan, J.; Morrow, M.; Tadros, A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Prospective assessment of lymphedema rates after axillary lymph node dissection in patients treated with neoadjuvant chemotherapy
    Meeting Abstract

    Montagna, G.; Zhang, J.; Sevilimedu, V.; Charyn, J.; Abbate, K. T.; Mehrara, B.; Morrow, M.; Barrio, A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Longitudinal prospective evaluation of quality of life after axillary lymph node dissection
    Meeting Abstract

    Zhang, J.; Montagna, G.; Sevilimedu, V.; Abbate, K. T.; Charyn, J.; Mehrara, B.; Morrow, M.; Barrio, A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Margin width does not impact local recurrence after neoadjuvant chemotherapy and breast conservation therapy
    Meeting Abstract

    Mrdutt, M. M.; Heerdt, A.; Sevilimedu, V.; Mamtani, A.; Barrio, A.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Can we successfully de-escalate axillary surgery in women 70 years or older with DCIS or early stage HR+/HER2- breast cancer undergoing mastectomy?
    Meeting Abstract

    Matar, R.; Barrio, A.; Sevilimedu, V.; Le, T.; Heerdt, A.; Morrow, M.; Tadros, A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • ASO author reflections: Residual disease in the breast after neoadjuvant chemotherapy does not mandate routine post-mastectomy radiation therapy/regional nodal irradiation
    Editorial

    Crown, A.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save